| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000233509.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.044427605 |
Resistant |
| ENSG00000233509.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.042177231 |
Resistant |
| ENSG00000233509.2 |
Avagacestat |
Skin cutaneous melanoma |
0.027473856 |
Resistant |
